Published on Tuesday November 03, 2020

Smooth Drug Development October 2020 News Release

We were working on the following new projects in October:

  • We signed a contract for data management and medical writing project of a clinical study in Russia.
  • We signed a contract for a medical writing project (INN: Ferri sulfas).

Clinical Department News:

  • We performed initiation visits of 2 sites and randomized first patients with COVID-19 in the II phase clinical trial.
  • The study of the drug for patients with rhinosinusitis was initiated by the Sponsor despite the difficult epidemiological situation.
  • The COVID-19 situation did not affect the reopening of the centers in the oncology clinical trial (patients with acute myeloid leukemia (AML)).
  • We performed CTA submission of phase III study of the Enoxaparin Sodium study for COVID-19 patients to MoH. All selection visits are done.
  • We finished enrollment in the Polmacoxib clinical trial.
  • Enrolment in Ethylmethylhydroxypyridine succinate project was restarted and achieved 105 subjects.